Regulation of E2F1 activity by acetylation

EMBO Journal

Volumn 19, Issue 4, 2000, Pages 662-671

  Martínez Balbás, Marian A ^a   Bauer, Uta Maria ^a   Nielsen, Søren J ^a   Brehm, Alexander ^a   Kouzarides, Tony ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Acetylation; E2F1; Histone deacetylase; P CAF; p300; Retinoblastoma protein

Indexed keywords

ACYLTRANSFERASE; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR E2F;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA BINDING; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0343484254     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.4.662     Document Type: Article

References (57)

1. Allen, K.E., de la Luna, S., Kerkhoven, R.M., Bernards, R. and La Thangue, N.B. (1997) Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors. J. Cell Sci., 110, 2819-2831.
2. Bagchi, S., Weinmann, R. and Raychaudhuri, P. (1991) The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2E Cell, 65, 1063-1072.
3. Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature, 384, 641-643.
4. Boyes, J., Byfield, P., Nakatani, Y. and Ogryzko, V. (1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature, 396, 594-598.
5. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J. and Kouzarides, T. (1998) Retinoblastoma protein recruits deacetylase to repress transcription. Nature, 391, 597-601.
6. Campero, M.R. and Flemmgton, E.K. (1997) Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by pRB tumor supressor protein. Proc. Natl Acad. Sci. USA, 94, 221-2226.
7. Cao, L., Faha, B., Dembski, M., Tsai, L.H., Harlow, E. and Dyson, N. (1992) Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature, 355, 176-179.
8. 1 cyclin-dependent kinase activity. Genes Dev., 9, 2873-2887.
9. de la Luna, S., Burden, M.J., Lee, C.-W. and La Thangue, N.B. (1996) Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J. Cell Sci., 109, 2443-2452.
10. Dynlacht, B.D., Flores, O., Lees, J.A. and Harlow, E. (1994) Differential regulation of E2F transactivation by cyclin cdk2 complexes. Genes Dev., 8, 1772-1786.
11. Dynlacht, B.D., Moberg, K., Lees, J.A., Harlow, E. and Zhu, L. (1997) Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Biol. Cell, 17, 3867-3875.
12. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev., 12, 2245-2262.
13. Flemington, E.K., Speck, S.H. and Kaelin, W.G. (1993) E2F1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl Acad Sci. USA, 90, 6914-6918.
14. Girling, R., Partridge, J.F., Bandara, L.R., Burden, N., Totty, N.F., Hsuan, J.J. and La Thangue, N.B. (1993) A new component of the transcription factor DRTF1/E2F. Nature, 362, 83-87.
15. Grunstein, M. (1997) Histone acetylation in chromatin structure and transcription. Nature, 389, 349-352.
16. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
17. Hagemeier, C., Cook, A. and Kouzarides, T. (1993) The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res., 21, 4998-5004.
18. Hall, M. and Peters, G. (1996) Genetic alterations of cyclins, cyclin-dependent kinases and cdk inhibitors in human cancer. Adv. Cancer Res., 68, 67-108.
19. Harlow, E. and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
20. Hateboer, G., Kerkhoven, R.M., Shvarts, A., Bernards, R. and Beijersbergen, R.L. (1996) Degradation of E2F by the ubiquitin -proteasome pathway - regulation by retinoblastoma family proteins and adenovirus transforming protein. Genes Dev., 10, 2960-2970.
21. Hebbes, T.R., Thorne, A.W. and Crane-Robinson, C.A. (1988) A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J., 7, 1395-1402.
22. Helin, K. (1998) Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev., 8, 28-35.
23. Helin, K., Lees, J.A., Vidal, M., Dyson, N., Harlow, E. and Fattaey, A. (1992) A cDNA encoding a pRb-binding protein with properties of the transcription factor E2F. Cell, 70, 337-350.
24. Hofmann, F., Martelli, F., Livingston, D.M. and Wang, Z.Y. (1996) The retinoblastoma gene-product protects E2F-1 from degradation by the ubiquitin - proteasome pathway. Genes Dev., 10, 2949-2959.
25. Hunter, T. and Pines, J. (1994) Cyclins and cancer. Cell, 79, 573-582.
26. Imhof, A., Yang, X.-J., Ogryzko, V.V., Nakatani, Y. Wolffe, A.P. and Ge, H. (1997) Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol., 7, 689-692.
27. Johnson, D.G., Schwarz, J.K., Cress, W.D. and Nevins, J.R. (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature, 365, 349-352.
28. Kaelin, W.G. et al. (1992) Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell, 70, 351-364.
29. Krek, W., Xu, G. and Livingston, D.M. (1995) Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell, 83, 1149-1158.
30. La Thangue, N.B. (1994) DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci., 19, 108-114.
31. Lindeman, G.J., Gaubatz, S., Livingston, D.M. and Ginsberg, D. (1997) The subcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl Acad. Sci. USA, 94, 5095-5100.
32. INK4A-mediated growth suppression. Mol. Cell. Biol., 16, 1047-1057.
33. Luo, R.X., Postigo, A.A. and Dean, D.C. (1998) Rb interacts with histone deacetylase to repress transcription. Cell, 92, 463-473.
34. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J., Trouche, D. and Harel-Bellan, A. (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature, 391, 601-605.
35. Martelli, F. and Livingston, D.M. (1999) Regulation of endogenous E2F1 stability by the retinoblastoma family proteins. Proc. Natl Acad. Sci. USA, 96, 2858-2863.
36. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T.S., La Thangue, N.B. and Kouzarides, T. (1995) Stimulation of E2F/DP1 transcriptional activity by MDM2 oncoprotein. Nature, 373, 691-694.
37. Mittnacht, S. (1998) Control of pRB phosphorylation. Curr. Opin. Genet. Dev., 8, 21-27.
38. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G. and Thanos, D. (1998) Acetylation of HMG I(Y) by CBP turns off INFβ expression by disrupting the enhanceosome. Mol. Cell, 2, 457-467.
39. Nevins, J.R. (1992) E2F: a link between the Rb tumor suppresser protein and viral oncoproteins. Science, 258, 424-129.
40. O'Connor, D.J., Lam, E.W.-F., Griffin, S., Zhong, S., Leighton, L.C., Burbidge, S.A. and Lu, X. (1995) Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J., 14, 6184-6192.
41. Ohtani, K., DeGregori, J. and Nevins, J.R. (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl Acad. Sci. USA, 92, 12146-12150.
42. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
43. Pearson, A. and Greenblatt, J. (1997) Modular organization of the E2F activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene, 15, 2643-2658.
44. Reid, J.L., Bannister, A.J., Zegerman, P., Martínez-Balbás, M.A. and Kouzarides, T. (1998) E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J., 17, 4469-4477.
45. Tao, Y., Kassatly, R.F., Cress, C.W. and Horowitz, J.M. (1997) Subunit composition determines E2F DNA-binding site specificity. Mol. Cell. Biol., 17, 6994-7007.
46. Trouche, D. and Kouzarides, T. (1996) E2F1 and E1A 12S have a homologous activation domain regulated by RB and CBP. Proc. Natl Acad. Sci. USA, 93, 1439-1442.
47. Trouche, D., Cook, A. and Kouzarides, T. (1996) The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res., 24, 4139-4145.
48. Vandel, L. and Kouzarides, T. (1999) Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase. EMBO J., 18, 4280-4291.
49. Weintraub, S.J., Chow, K., Luo, R.X., Zhang, S.H., He, S. and Dean, D.C. (1995) Mechanism of active transcription repression by the retinoblastoma protein. Nature, 375, 812-815.
50. Wu, C.-L., Zukerberg, L.R., Ngwu, C., Harlow, E. and Lees, J.A. (1995) In vivo association of E2F and DP family proteins. Mol. Cell. Biol., 15, 2536-2546.
51. Xu, M., Sheppard, K.A., Peng, C.Y. Yee, A.S. and Piwnica-Worms, H. (1994) Cyclin A-cdk2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol., 14, 8420-8431.
52. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. and Dyson, N. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85, 537-548.
53. Yang, X.J., Ogryzko, V., Nishikawa, J., Howard, B. and Nakatani, Y. (1996) A p300/CBP-associatcd factor that competes with the adenoviral oncoprotein E1a. Nature, 382, 319-324.
54. Zamanian, M. and La Thangue, N.B. (1992) Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J., 11, 2603-2610.
55. 1 arrest triggered by p16INK4a. TGFβ and contact inhibition. Cell, 97, 53-61.
56. Zhang, W. and Bieker, J.J. (1998) Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl Acad. Sci. USA, 95, 9855-9860.
57. Zheng, N., Fraenkel, E., Pabo, C.O. and Pavletich, N.P. (1999) Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes Dev., 13, 666-674.